Evidence map›Paper›PMID 20626729›Full record

ArticleAlcoholism, clinical and experimental research2010

Effects of a novel cognition-enhancing agent on fetal ethanol-induced learning deficits.

Daniel D Savage, Martina J Rosenberg, Christina R Wolff, Katherine G Akers, Ahmed El-Emawy, Miranda C Staples, Rafael K Varaschin, Carrie A Wright, Jessica L Seidel, Kevin K Caldwell and 1 more

Abstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Assessment of GABANeuroscience letters · 2026
    Article
  3. Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. The histamine HAlcohol (Fayetteville, N.Y.) · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Daniel D SavageDepartment of Neurosciences, MSC08 4740, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA. dsavage@salud.unm.edu
Martina J Rosenberg
Christina R Wolff
Katherine G Akers
Ahmed El-Emawy
Miranda C Staples
Rafael K Varaschin
Carrie A Wright
Jessica L Seidel
Kevin K Caldwell
Derek A Hamilton
University of New Mexico · US

Funding

Understanding neurophysiological deficits in response inhibition in children with FASDP50AA022534 · NIAAA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Carlos Fernando Valenzuela · 2014 to 2026
$21.5M
Fetal ethanol-induced behavioral deficits: Mechanisms, diagnoses and interventionP20AA017068 · NIAAA · UNIVERSITY OF NEW MEXICO · PI SAVAGE, DANIEL D. · 2008 to 2012
$2.6M
Fetal Ethanol Effects on Histaminergic Regulation of NeurotransmissionR01AA019884 · NIAAA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI SAVAGE, DANIEL D. · 2011 to 2015
$1.5M
Screening Putative Therapeutic Agents for Fetal Ethanol-Induced Learning DeficitsR21AA016619 · NIAAA · UNIVERSITY OF NEW MEXICO · PI SAVAGE, DANIEL D. · 2007 to 2008
$394k
RESEARCH TRAINING IN MENTAL HEALTH AND AGINGT32MH019104 · NIMH · STANFORD UNIVERSITY · PI THOMPSON, LARRY W · 1989 to 1998
–
NIAAA NIH HHS AA016619NIAAA NIH HHS AA017068NIAAA NIH HHS P20 AA017068NIAAA NIH HHS P50 AA022534NIAAA NIH HHS R01 AA019884NIAAA NIH HHS R21 AA016619NIMH NIH HHS MH019104NIMH NIH HHS T32 MH019104
6 · The paper itself

Abstract

backgroundDrinking during pregnancy has been associated with learning disabilities in affected offspring. At present, there are no clinically effective pharmacotherapeutic interventions for these learning deficits. Here, we examined the effects of ABT-239, a histamine H₃ receptor antagonist, on fetal ethanol-induced fear conditioning and spatial memory deficits. METHODS AND

resultsLong-Evans rat dams stably consumed a mean of 2.82 g ethanol/kg during a 4-hour period each day during pregnancy. This voluntary drinking pattern produced a mean peak serum ethanol level of 84 mg/dl. Maternal weight gain, litter size and birth weights were not different between the ethanol-consuming and control groups. Female adult offspring from the control and fetal alcohol-exposed (FAE) groups received saline or 1 mg ABT-239/kg 30 minutes prior to fear conditioning training. Three days later, freezing time to the context was significantly reduced in saline-treated FAE rats compared to control. Freezing time in ABT-239-treated FAE rats was not different than that in controls. In the spatial navigation study, adult male offspring received a single injection of saline or ABT-239 30 minutes prior to 12 training trials on a fixed platform version of the Morris Water Task. All rats reached the same performance asymptote on Trials 9 to 12 on Day 1. However, 4 days later, first-trial retention of platform location was significantly worse in the saline-treated FAE rats compared control offspring. Retention by ABT-239-treated FAE rats was similar to that by controls. ABT-239's effect on spatial memory retention in FAE rats was dose dependent.

conclusionsThese results suggest that ABT-239 administered prior to training can improve retention of acquired information by FAE offspring on more challenging versions of hippocampal-sensitive learning tasks. Further, the differential effects of ABT-239 in FAE offspring compared to controls raises questions about the impact of fetal ethanol exposure on histaminergic neurotransmission in affected offspring.

Indexed as

AnimalsBenzofuransConditioning, ClassicalDisease Models, AnimalEthanolFemaleHistamine AntagonistsLearning DisabilitiesMaleMemory DisordersNootropic AgentsPregnancyPrenatal Exposure Delayed EffectsPyrrolidinesRatsRats, Long-EvansBenzofuransbenzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)-EthanolHistamine AntagonistsNootropic AgentsPyrrolidinesReceptors, Histamine H3

Identifiers

PMID20626729
PMCPMC3654805
OpenAlexW2166042148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.